Molnupiravir will be offered to at-risk patients who already have the coronavirus. It is not a substitute for the COVID-19 vaccine, UK authorities said.
READ MORE : [ Ссылка ]
Subscribe to our channel: [ Ссылка ]
Watch our LIVE here: [ Ссылка ]
Subscribe to our thematic channels:
NoComment: [ Ссылка ]
Euronews Green: [ Ссылка ]
Euronews Next: [ Ссылка ]
Euronews Travel: [ Ссылка ]
Euronews is available on YouTube in 12 languages: [ Ссылка ]
#Health
![](https://i.ytimg.com/vi/yBvnQhaA5N0/mqdefault.jpg)